Allergy and Immunology, Allergy · Springfield, IL
NPI
1477553931
Since 2005
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1025 S 6th St
Springfield, IL, 62703
Phone (217) 528-7541
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
2,205 services
Medicare patients, 2024
129
Average age 69
Drug cost, 2024
$1.3M
1,180 prescriptions
Company payments, 2025
$1,151
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Renu C Govindaiah was code 95004 (test - miscellaneous), 1,148 times for 24 patients. In total Renu C Govindaiah billed 2,205 services in 23 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,148 | 24 | $2.79 | $3,201 |
| 95165 Treatment - Miscellaneous | Office | 276 | 23 | $10.16 | $2,805 |
| 95117 Treatment - Miscellaneous | Office | 256 | 19 | $8.58 | $2,197 |
| 99213 Office E&M - Established | Office | 62 | 51 | $61.32 | $3,802 |
| 99214 Office E&M - Established | Office | 38 | 30 | $91.17 | $3,464 |
| 96160 E&M - Miscellaneous | Office | 24 | 22 | $2.10 | $50.39 |
| 99203 Office E&M - New | Office | 22 | 22 | $81.25 | $1,788 |
| 99204 Office E&M - New | Office | 14 | 14 | $94.89 | $1,328 |
By year: 2022 $25K for 2,972 services; 2023 $24K for 3,063 services; 2024 $21K for 2,205 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 13 | $2.94 | $44.13 |
Medicare prescription drug claims, 2024
In 2024, the drug Renu C Govindaiah prescribed most often to Medicare patients was Montelukast Sodium, with 253 prescriptions and refills. In total Renu C Govindaiah wrote 1,180 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 253 | 572 | 65 | $1,580 |
| Fluticasone Propionate Generic | 92 | 199 | 30 | $1,689 |
| Azelastine Hcl Generic | 83 | 150 | 29 | $2,953 |
| Famotidine Generic | 73 | 147 | 23 | $420 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 65 | 71 | 37 | $1,242 |
| Prednisone Generic | 41 | 41 | 22 | $99.3 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 39 | 65 | Under 11 | $42K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 38 | 60 | 13 | $4,059 |
| Breo Ellipta Fluticasone/Vilanterol | 36 | 47 | Under 11 | $18K |
| Arnuity Ellipta Fluticasone Furoate | 34 | 58 | Under 11 | $15K |
| Ipratropium Bromide Generic | 27 | 59 | 18 | $534 |
| Levocetirizine Dihydrochloride Generic | 23 | 27 | Under 11 | $73.54 |
| Dupixent Syringe Dupilumab | 23 | 32 | Under 11 | $126K |
| Xolair Omalizumab | 23 | 39 | Under 11 | $114K |
| Epinephrine Generic | 21 | 23 | 21 | $3,665 |
Brand drugs: 352 claims; generic drugs: 828 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Renu C Govindaiah $1,151 ($1,151 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $196.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $196 |
| Genzyme Corporation SNY | 9 | $164 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $117 |
| GlaxoSmithKline, LLC. GSK | 6 | $108 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 4 | $92.21 |
| Genentech USA, Inc. ROG.SW | 3 | $78.47 |
| CSL Behring CSL.AX | 4 | $74.06 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $59.19 |
| Optinose US, Inc. | 2 | $50.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.